Roy Jensen, M.D.
- Professor, Department of Pathology & Laboratory Medicine (KUMC)
- Professor, Cancer Biology (KUMC)
- Director, The University of Kansas Cancer Center
- William R. Jewell, M.D. Distinguished Kansas Masonic Professor of Cancer Research and
- Director, Kansas Masonic Cancer Research Institute, KUMC
Contact Info
Medical Center, Kansas City
Personal Links
Biography —
Dr. Jensen was appointed the director of The University of Kansas Cancer Center (KU Cancer Center) in 2004. As a result of a broad-based university, community, and regional effort, The University of Kansas Cancer Center was designated as a cancer center by the National Cancer Institute (NCI) in July 2012. Dr. Jensen is currently Professor of Pathology and Laboratory Medicine, Professor of Anatomy and Cell Biology, Professor of Cancer Biology, and the William R. Jewell, M.D. Distinguished Kansas Masonic Professor at the University of Kansas Medical Center. Prior to his appointment at KU Cancer Center, Jensen was a member of the Vanderbilt-Ingram Cancer Center and a faculty member in Pathology, Cell Biology, and Cancer Biology for 13 years.
Research —
Dr. Jensen's research has been with the breast cancer susceptibility gene 1 (BRCA1) and breast cancer for more than 20 years. He was part of the team to provide the first evidence that BRCA1 was a tumor suppressor. Currently, Jensen's lab has several projects aimed at understanding BRCA1 regulation and how we might enhance the ability of BRCA1 to act as a tumor suppressor.